ImageneBio, Inc.
IMA
$5.85
-$0.17-2.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.12% | -226.68% | -24.81% | -26.29% | -51.18% |
| Total Depreciation and Amortization | 80.97% | 278.05% | 2.50% | -14.89% | -37.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.91% | 5,426.18% | 57.14% | 1,446.15% | -101.01% |
| Change in Net Operating Assets | 92.77% | -161.57% | -231.89% | -212.10% | 230.83% |
| Cash from Operations | 66.42% | -80.62% | -64.61% | -108.06% | -28.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -88.15% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 100.00% | -- | -- | -- | -- |
| Other Investing Activities | -278.30% | -- | -- | -- | -- |
| Cash from Investing | 69.35% | -- | -- | -- | -88.15% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 2,686.69% | -10,916.67% | 96.97% | -- |
| Cash from Financing | -100.00% | 840.49% | 48,111.11% | -99.61% | -- |
| Foreign Exchange rate Adjustments | -107.25% | 5,192.31% | -533.33% | 110.00% | -126.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.88% | 8,706.98% | 115.32% | -305.48% | 303.25% |